Background: KCHN2 encodes the K V 11.1 potassium channel responsible for I Kr , a major repolarization current during the cardiomyocyte action potential. Variants in KCNH2 that decrease I Kr can cause Type 2 Long QT syndrome, usually due to mistrafficking to the cell surface. Accurately discriminating between variants with normal and abnormal trafficking would help clinicians identify and treat individuals at risk of a major cardiac event. The volume of reported non-synonymous KCNH2 variants preclude the use of conventional electrophysiologic methods for functional study.
CLINICAL IMPLICATIONS
Hundreds of KCNH2 variants have been observed to date, and thousands more will be found as clinical and population sequencing efforts become increasingly widespread. The major mechanism of K V 11.1 loss of function is misfolding and failure to traffic to the cell surface. Deep mutational scanning of KCNH2 trafficking is a scalable, high-throughput method that can help identify new loss of function variants and decipher the large number of KCNH2 variants being found in the population.
INTRODUCTION
KCNH2, also known as the human Ether-à-go-go-Related Gene (hERG), encodes the rapid component of the delayed inward-rectifying, voltage-gated, cardiac potassium channel K V 11.1. This channel produces a major repolarizing current in cardiomyocytes, I Kr . KCNH2 lossof-function variants are the second most common cause of congenital long QT syndrome (LQT2; MIM: #613688, Figure 1A ). 1 KCNH2 gain-of-function variants are the most common cause of short QT syndrome (SQTS; MIM: #609620). 2 As the names suggest, LQT2 is characterized by a prolonged QT interval on the electrocardiogram, and SQTS, a rarer disease, is characterized by a short QT interval. Both LQT2 and SQTS predispose individuals to syncope and sudden death. 2, 3 To date, more than 400 KCNH2 variants have been observed in patients with arrhythmias or sudden death, and over 500 KCNH2 variants are present in the Genome Aggregation database (gnomAD), a large database of presumably mostly unaffected individuals. 1, [4] [5] [6] [7] [8] [9] With the onset of large population sequencing projects and increasing use of clinical genetic testing, the number of observed KCNH2 variants is rapidly growing, much faster than the detailed characterization of these variants. 10 An important challenge for KCNH2 variant annotation is the identification and characterization of potentially disease-causing KCNH2 variants found in individuals with or without a clinical phenotype. K V 11.1 is an 1,159 residue protein with six membrane-spanning helices that forms a homotetrameric voltage-gated potassium channel at the plasma membrane surface in cardiomyocytes. A very common mechanism by which pathogenic variants cause protein dysfunction is destabilization-induced misfolding. [11] [12] [13] [14] For K V 11.1, misfolding most commonly causes loss of trafficking to the plasma membrane, resulting in fewer functional channels at the cell surface ( Figure 1B ). [15] [16] [17] 178 /211 (84%) KCNH2 variants associated with LQT2 whose cell surface abundance has been assayed have defective trafficking to the cell surface ( Figure   1C ). [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] Here, we develop a deep mutational scanning (DMS) method that combines saturation mutagenesis with a high-throughput flow-cytometry-based trafficking assay. This approach offers a unique opportunity to generate high-throughput experimental data for hundreds or thousands of single codon substitutions in a multiplexed experiment. This provides complementary information to in silico predictions 29, 30 and other functional characterization techniques, such as automated patch clamp electrophysiology 31 and CRISPR-generated, or naturally-occurring, variants in induced pluripotent stem cell-derived cardiomyocytes. 32 Here we present a DMS of a transmembrane helix of KCNH2. We generate 220 variants in an 11 amino acid region of KCNH2 and assay the impact of these variants on cell surface abundance with a multiplexed flow cytometry assay. We determine cell surface abundance scores for these variants, and find that these scores correlate strongly with ion channel topology. This method predicts new deleterious variants in KCNH2 likely to induce LQT2 and can be expanded to the rest of KCNH2 and other membrane proteins.
METHODS

KCNH2 mutagenesis
We modified a previously published promoterless dsRed-Express-derivative plasmid 33 and inserted wildtype KCNH2 (hERG 1a; ENST00000262186) immediately adjacent to a recombinase AttB site. A "tile" system was created to divide up the size of fragments digested during molecular biology experiments by using naturally-occurring restriction enzyme sites and generating additional sites by synonymous mutations, which were introduced by a Quikchange Lightning Multi kit (Agilent). In this way, we divided wildtype KCNH2 into 5 tiles of 500-800 base pairs ( Figure S1 ). A previously published 34 9 amino acid HA tag with surrounding 4 amino acid linkers (NSEHYPYDVPDYAVTFE) was inserted between amino acids T443 and E444 (in the extracellular region between the S1 and S2 helices) by inverse PCR 35 (Table S1) . This tag has been demonstrated previously not to affect the electrophysiological properties of the channel. 34 The promoterless "wildtype" plasmid (AttB-KCNH2-HA:IRES:mCherry) used for stable line generation contained an AttB recombination sequence (for genome integration), wildtype KCNH2-HA, an internal ribosome entry site (IRES), an mCherry reporter, and a SV40 termination sequence. A barcode integration site was located adjacent to the attB site, which allowed tagging of variants with random DNA barcodes (see below). We also generated a single tile plasmid (Tile 3-KCNH2) containing only Tile 3 (c.1474-1966), which was cloned into the dsRed-Express-derivative plasmid, surrounded by BglII and NdeI restriction sites.
Comprehensive codon mutagenesis was performed by inverse PCR of the Tile 3-
KCNH2 plasmid with 1 primer pair per codon. Each forward primer contained 5'NNN (the nucleotide, N, is a mix of A/C/G/T), encoding all 64 possible codons. 35 11 PCR products (corresponding to the 11 mutated codons, residues 545-555; Figure S2A ) were pooled, PCR purified, and phosphorylated with T4 Polynucleotide Kinase (New England Biolabs, NEB), ligated with T4 DNA ligase (NEB), and incubated with DpnI (NEB). The products were then PCR Purified (Qiagen) and electroporated into MegaX DH10B Electrocomp Cells (ThermoFisher) with a Gene Pulser Electroporation System (Bio-Rad). Plating experiments using various dilutions of the library onto LB-Ampicillin plates were performed to determine transformation efficiency and library diversity. The mutant Tile 3 plasmid pool was then subcloned into the AttB-KCNH2-HA:IRES:mCherry plasmid by restriction digest with BglII and NdeI (NEB), ligated with T4 ligase (NEB), and electroporated as described above. An 18-mer poly-N barcode was created by annealing primers (Table S1 ) and extended to make fully double stranded with Klenow polymerase (NEB). The barcode was then PCR purified (Qiagen) and inserted adjacent to the AttB site by restriction digest with BsiWI and XbaI (NEB), and the library was electroporated as described above. At each cloning step, selected colonies were Sanger sequenced to verify the success of each step and to ensure sufficient variant library and barcode diversity.
Subassembly to link barcodes and mutants
To link barcodes to mutants, the library was digested with NdeI (NEB), gel extracted (Qiagen), and ligated with T4 ligase (NEB), which caused intramolecular ligation to bring the barcode adjacent to the mutated Tile 3 (Table S1 ). PCR was performed with Q5 polymerase (NEB) following manufacturer's instructions with 10 PCR cycles (primers listed in Table S1 ).
Samples were purified with Ampure XP beads (Beckman Coulter) following manufacturer's instructions, verified by Bioanalyzer and qPCR, and sequenced on an Illumina NovaSeq instrument with 150 base paired end sequencing. Reads were analyzed with a custom python script to identify barcodes where over 80% of reads associated with a single mutation.
Generation of stable cell lines
HEK293 cells were grown in alpha MEM (#15-012-CV, Corning) with 10% FBS, 1% GlutaMax (Gibco), and in an incubator at 37 °C with 5% CO 2 . The library was integrated into a previously published HEK293T "landing pad" cell line. 33 This cell line contains a landing pad safe harbor location engineered to contain an AttP site (Bxb1 recombination site) between a tetracycline-inducible promoter and a Blue Fluorescent Protein gene (HEK TetBxb1BFP). Cells were grown to 40-60% confluency before transfection. On day 0, this cell line was transfected with a plasmid expressing Bxb1 integrase (pCAG-NLS-HA-Bxb1; Addgene #51271, a gift from Pawel Pelczar 36 ) by transient transfection with FuGENE 6 (Promega). On day 1, the cells were transfected with the library of KCNH2 variants using FuGENE 6. On day 6, cells were incubated in 1 µg/ml doxycycline in HEK media to induce expression from the landing pad tetracyclinesensitive promoter. The resulting cell lines that integrated the plasmid had a single variant expressed from the landing pad, along with mCherry. Non-integrated cells expressed tagBFP and were mCherry-negative.
High-throughput quantitation of variant surface trafficking using cell sorting
The HEK293T-integrated library was sorted with fluorescence activated cell sorting (FACS) to obtain cells that had successfully integrated an AttB-containing plasmid. 24 hours after doxycycline was added, cells were harvested with TrypLE Express (Thermo Fisher), resuspended in HEK media, spun at 500g for 2 minutes, and resuspended in divalent-free PBS with 1% bovine serum albumin (BSA). Cells were filtered and mCherry-positive, BFP-negative cells were sorted with a BD Aria III instrument. Filters used for sorting were 535 nm (excitation) and 610/20 nm (emission) for mCherry and 405 nm (excitation) and 450/50 nm (emission) for BFP. Cells were sorted into PureCoat plates (Corning) to enhance cell recovery and recovered for at least 12 hours before moving to non-PureCoat plates. 1x Penicillin-Streptomycin (Gibco) was used in cell medium for at least 48 hours after cell sorting to protect from infection, after which antibiotic-free medium was again utilized.
After sorted cells were recovered and grown to confluency, a surface staining and fluorescence-activated cell sorting assay was used to assay cell surface abundance of the library. Cells were harvested with TrypLE Express (Thermo Fisher), resuspended in HEK media, spun at 500g for 2 minutes, and resuspended in divalent-free PBS with 1% BSA. Cells were filtered and incubated in a 1:500 solution of mouse anti-HA antibody covalently bound to Alexa 647 (Cell Signaling 6E2, product #3444). Cells were incubated with the antibody by shaking vigorously for 15-30 minutes, then spun at 500g for 2 minutes. Pelleted cells were then resuspended in PBS with 1% BSA and filtered. A second cell sort was then performed. Cells that were both mCherry positive and tagBFP negative, indicating successful plasmid integration, were identified as described above. These cells were sorted into 4 groups depending on level of Alexa 647 signal ( Figure S2 ). The Alexa 647(-) pool was defined based on the staining levels of control cells not treated with doxycycline. The remaining 3 pools were chosen to have approximately the same number of cells in each pool. The four pools of sorted cells were replated and grown to confluency as described above. After multiple days of growth to achieve >2 million cells per pool, cells were harvested using TrypLE Express (Thermo Fisher) and pelleted at 1 million cells/tube for frozen storage.
Illumina sequencing of libraries
DNA was isolated from each of the four cell pools with 100 µL QuickExtract (Lucigen) per 1 million cells following the manufacturer's instructions. PCR to amplify the barcode for Illumina sequencing was performed on 2.5 µL of isolated DNA (primers listed in Table S1 ) with Q5 polymerase (NEB), following manufacturer's instructions with between 25-35 cycles. Illumina libraries were cleaned with AmpureXP beads (Beckman Coulter) following manufacturer's instructions, assessed with Bioanalyzer and qPCR, and sequenced on an Illumina NovaSeq instrument with 150 base paired end sequencing. Sequencing reads were de-multiplexed and processed with custom python scripts to identify the barcode present in each read.
Calculation of trafficking scores
For each barcode, a raw trafficking score was calculated as the weighted average of the abundance of each barcode (i) in the four pools:
Where Pool !,! is the fraction of the i th barcode in the n th pool of sorted cells; n ranges from 1 (no K V 11.1 present, i.e. no AF647 signal) to 4 (high abundance of K V 11.1, i.e. high AF647 signal). The scores were then aggregated by variant and normalized with a linear transformation so that trafficking score ranged from 0 (barcodes only observed in the AF647 negative pool) to 100 for WT. The scores were then averaged across the 2 replicate experiments (separate transfections of the mutant library pool).
Flow cytometry, confocal microscopy, and patch clamping assay of individual KCNH2
variants Single variants were introduced by mutagenesis of the Tile 3-KCNH2 plasmid (Table S1) using the Quikchange Lightning Multi kit (Agilent), with 1 primer per variant, following the manufacturer's instructions. After the mutation was verified with Sanger sequencing, the mutant Tile 3 was subcloned into the full length AttB-KCNH2-HA:IRES:mCherry by restriction digest with BglII and NdeI (NEB) and ligation with T4 ligase (NEB). Plasmids were then verified with Sanger sequencing. Stable HEK293T landing pad cell lines were generated for each mutant as described above. For flow cytometry, cells were stained with an anti-HA antibody and assayed for cell surface abundance as described above. For confocal microscopy, live cells were first stained with an anti-HA antibody directly conjugated to Alexa 647 as described above. Then, cells were fixed for 10 minutes in 4% paraformaldehyde, washed in PBS, permeabilized in 0.2% Cells were then incubated for 60 min at 10 °C while shaking on a rotating platform at 500 rpm, before being dispensed into the 384 wells of the patch engine.
Data analysis of patch clamp recording
To measure the voltage dependence of activation, cells were depolarized to a range of potentials (from -50 mV to +70 mV in 10 mV increments) for 1 s before stepping to -120 mV to record tail currents. The mid-point of the voltage dependence of activation (V 0.5 ) was determined by fitting a Boltzmann distribution to a plot of the peak tail currents against the voltage of the depolarizing step, using Equation 2:
where: V 0.5 is the half-maximum activation voltage, Vt is the test potential, k is the slope factor and g max is the maximum conductance.
To measure the rate of hERG channel closure (deactivation), cells were depolarized to +40 mV for 1 s before stepping to a range of tail potentials (from +20 to −150 mV in 10 mV increments) for 3 s. The decay component, after the initial 'hooked' current, represents K V 11. 
RESULTS
We modified a flow cytometry-based cell-surface trafficking assay 37 for compatibility with a DMS of KCNH2. To accomplish this, we inserted an hemagglutinin (HA) tag 34 into the first extracellular loop of KCNH2, overexpressed this plasmid in HEK293 cells, and isolated cells using flow cytometry. 33 Control variants of KCNH2 were generated within the HA-KCNH2 construct, and trafficking characteristics were validated with flow cytometry and confocal microscopy (Figure 2A ). Wildtype HA-KCNH2 had a high surface abundance as detected by both flow cytometry or confocal microscopy ( Figure 2B ). In contrast, G601S and A561V, which have previously been described to have mistrafficking-related loss of function defects, 38, 39 had reduced cell surface abundance with both methods ( Figure 2B ).
Deep mutational scan of 11 amino acid region of KCNH2
We next generated a barcoded plasmid library of nearly every possible variant in an 11 amino acid region (residues 545-555) of KCNH2 using PCR with degenerate primers 35 (Table   S1 ). After subassembly 40 to link barcodes to variants, 14,466 unique barcodes were detected, which included 220/231 possible missense variants ( Figure S3 ). The 11-amino acid experiment successfully distinguished between two control classes of variants, nonsense variants (predicted to have no channel function) and synonymous variants (predicted to have wildtype channel function; Figure 3A ). Initial trafficking scores were calculated from a weighted average of each variant's abundance in the four sorted pools. These scores were averaged across two independently transfected and sorted replicate experiments. From a range of possible initial trafficking scores between 1 and 4, the nonsense variants had an average raw score of 1.09, whereas WT had an average score of 2.7 (Equation 1). We generated normalized scores such that 0 was the lowest possible score and 100 was the average score for WT ( Figure 3 ). The missense scores ranged widely from loss of function to wildtype-like, and the mean score for all missense variants was 54.8 ( Figure 3A and B) . Trafficking scores were highly consistent across the two replicate experiments (Spearman's r = 0.77).
Trafficking scores and K V 11.1 topology
We explored the structural basis of the trafficking scores with a three-dimensional structure of K V 11.1 (Figure 4 ). 41 Residues Y545-V549 tolerated substitutions more than residues L550-C555, especially secondary structure-disruptive substitutions (glycine and proline) and hydrophilic substitutions ( Figure 3B ). These observations are consistent with the topology and position within the membrane of the pilot region: residues 545-549 join the S4 and S5 helices on the intracellular membrane leaflet, a segment transitioning from random coil to α-helical secondary structure (Figure 4 ). Missense substitutions at residues 545-549 were less likely on average to induce mistrafficking compared to residues 550-555, a mean trafficking score of 70.2 versus 42.2, respectively. In contrast, residues 550-555, closer to the membrane interior, were less tolerant to any substitution, especially polar and charged residues. The trafficking scores correlated modestly with computational predictions, with a Spearman's ρ of 0.31 and 0.21 with PROVEAN and PolyPhen-2, respectively (File S1).
Validation of trafficking assay scores
To validate our trafficking scores, we selected five variants for further characterization.
These variants were selected based on their unintuitive DMS trafficking results: L552N and A547D are in regions intolerant of hydrophilic substitution yet had a trafficking score like WT (scores of 108 and 99, respectively); M554A is in a region tolerant of hydrophobic substitution yet does not traffic (score of 4); and M554W is a disruptive substitution yet traffics like WT (score of 99), in contrast to M554A. F551Y. In single variant validation experiments, these five variants had confocal and flow cytometry cell surface abundance concordant with their DMS scores ( Figure 5 and Table 1 ). All variants in the validation set are predicted to be deleterious by PROVEAN and PolyPhen-2.
In addition, we examined four variants in the studied region that have previously been observed in literature reports or individuals in the gnomAD database. 9 L552S was previously reported as a loss of trafficking variant 15 and has been observed in 90 cases of Long QT syndrome in the literature, 28 unaffected individuals, and 20 alleles in the gnomAD database.
Our DMS score for L552S was 25, consistent with the strong association with LQT2 and a loss of trafficking as previously reported. 15 Three other variants, A547T, V549M, and F551L, were not observed in any literature cases of Long QT Syndrome and have been observed in 1-2 cases in the gnomAD database, too few to assess relevance from patient data alone. All of these variants had normal trafficking scores (Table S2 ). Thus, the DMS trafficking scores are consistent with the available data for variants in this region.
To further assess the trafficking results, we collected planar patch clamp data on the five validation variants. Consistent with its loss of trafficking DMS score (score of 4) and its loss of trafficking in validation experiments, M554A also had a total loss of I Kr . Surprisingly, the other three validation variants, which had detectable trafficking by DMS and in validation experiments, also had loss of function defects by patch clamp (Figure 6 ). Despite being present at the cell surface ( Figure 5 ), M554W and A547D did not produce measurable I Kr , while L553N had detectable I Kr , but with lowered peak tail current and faster deactivation rate, essentially producing a loss-of-function phenotype (Figure 6 ). Therefore, the high-throughput trafficking scores were successful at identifying loss of function variants that acted through a trafficking mechanism, but not by other mechanisms.
DISCUSSION
A high-throughput assay for identifying KCNH2 variant trafficking.
We developed a scalable, multiplexed flow cytometry and high-throughput sequencing assay to measure the cell surface abundance of hundreds (and potentially thousands) of variants in KCNH2. We generated trafficking scores for 220/231 possible missense variants in an 11 amino acid region of KCNH2. We validated these scores in several ways. First, the scores correlated very well (Spearman ρ = 0.77) across the two replicate experiments. Second, the scores distinguished nonsense from synonymous variants (Figure 3 ). Finally, 5/5 missense variants with a range of surprising, unintuitive trafficking scores were validated by flow cytometry and confocal immunocytochemistry on single variants ( Figure 5 ). Therefore, we believe these scores accurately capture cell surface abundance, which is the major mechanism for ~80% of all LQT variants studied to date. [15] [16] [17] 
Improved understanding of KCNH2 trafficking deficiency
From our trafficking data, we could observe two sub-domains in the 11-residue pilot region: a more exposed, hydrophilic region (residues 545-549) and a more buried hydrophobic region (residues 550-555). We find a difference in average trafficking behavior of variants in these two regions. In the hydrophilic region, hydrophilic substitutions were tolerated, whereas in the hydrophobic region, hydrophilic substitutions were more likely to lead to compromised trafficking. The tolerance of hydrophobic and hydrophilic substitutions in this pilot region additionally reflects the known topology of the KCNH2 S5 helix, hydrophilic residues being less well-tolerated near the middle of the membrane bilayer ( Figures 3B and 4) . Our trafficking data have a Spearman's ρ of 0.31 and 0.21 with PROVEAN and PolyPhen-2, respectively, suggesting modest overlap in information contained in each feature. L553N trafficked like WT and produced measurable peak tail current; however, this variant had a dramatically faster deactivation time, the time it takes the channel to stop conducting after the cell is repolarized ( Figure 6 ). L553 points in between residues N658 and V659 in the S6 helix within the same subunit. 42 Both residues are known to accelerate deactivation and the asparagine (N) substitution could stabilize an interaction between N658 and L553N resulting in a preferred deactivated state ( Figure 6D ).
Approaches to studying KCNH2 variants
This work represents a new tool to studying KCNH2 variants in high-throughput. Several studies have previously quantified trafficking of K V 11.1, typically using assays that rely on
Western blotting or confocal imaging, which are not scalable to thousands of variants. 17, 43 Recent advances in automated patch clamp electrophysiology have enabled the rapid characterization of dozens of voltage-gated potassium channel variants, 31, 44 and induced pluripotent stem cell derived cardiomyocytes show promise to characterizing KCNH2 variants in a non-heterologous system. However, the throughput of these methods does not allow for the rapid screening of the thousands of possible variants in KCNH2. In contrast, computational predictions like Polyphen2 or PROVEAN can be easily generated for every variant in KCNH2.
However, while these computational predictions can partially predict disease risk, they are imperfect and often cannot capture the subtle differences among different nearby residues (File S1).
Improving the prediction of KCNH2 variant pathogenicity.
Our assay has the potential to sample nearly all possible amino acid substitutions in KCNH2 in an unbiased manner. This will provide a database for patients and clinicians to identify the effect a previously uncharacterized mutation may have on patient disease propensity. Future work will expand this method to much larger regions of KCNH2, with a focus on regions enriched for known LQT variants (Figure 1 ). Accomplishing this will allow a more comprehensive exploration of the relationship between KCNH2 trafficking deficiency and disease risk. The method presented here is in principle generalizable to other cardiac ion channels, and all other proteins found at the plasma membrane, approximately 30% of the human proteome. [11] [12] [13] [14] 
Limitations.
Seven variants were unable to be analyzed due to lack of barcoding during the generation of the KCNH2 plasmid library. Additionally, our work was done in HEK cells and not cardiomyocytes. Therefore, we do not account for the expression of additional KCNH2 splice variants and other subunits that may contribute to the inward rectifier current that underlies I Kr in cardiomyocytes. Our assay investigates trafficking of homozygous KCNH2 1a variants with the most common allele (K897). Subsequent studies will investigate the effects of coexpression with WT splice isoforms, 1a and 1b, axillary subunits, e.g. KCNE2, and in the presence of common polymorphisms (K897T and R1047L).
Conclusion
We have developed a high-throughput trafficking assay to characterize cell surface expression of KCNH2 variants in a massively parallel fashion. This method can be expanded to other ion channels and transmembrane proteins where altered cell surface abundance is a major mechanism of disease pathogenesis. 
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FIGURES
Figure 3: Deep mutational scan identifies trafficking-defective variants
A) The 11-residue pilot saturation mutagenesis experiment. Trafficking scores between nonsense and synonymous variants were highly separated, and were used to determine "wildtype" and "loss of function" levels and calculate normalized scores, which are shown in the plot. The missense variants had a range of scores from near-wildtype to loss-of-function. B) The wildtype residue is indicated in the leftmost column and amino-acid substitution is indicated on the top row. Blue indicates that the variant did not express to the plasma membrane, white indicates the variant traffics like WT, and red indicates the variant traffics more than WT. Out of the 220 variants assayed, 86 were WT-like (score > 75), 57 were mild loss-of-trafficking (75 > score > 50), 48 were loss-of-trafficking (50 > score > 25), and 73 were severe loss-of-trafficking In silico model of the protein product of KCNH2 (K V 11.1) with residues mutagenized in a pilot study of a high-throughput trafficking assay highlighted as red or blue spheres. These residues are on the intracellular half of the S5 transmembrane helix. The red to blue transition from V549 to L550 reflects the transition from residues tolerant of hydrophilic substitution to residues intolerant of hydrophilic substitution, respectively, as observed in the high-throughput trafficking assay ( Figure 3B ).
Figure 5: Validation of trafficking scores
Validation of selected variants by analytical flow cytometry (left) and confocal microscopy (right).
In the leftmost column, DMS score is indicated directly below variant name. X-axis is mCherry fluorescence (indicating K V 11.1 expression), the y-axis is surface stained K V 11.1 (protein product of KCNH2). The remaining columns are extracellularly stained K V 11.1 (AF647, purple)
intracellularly stained K V 11.1 (AF488, green), and both merged with DAPI stained nucleus (blue).
Figure 6: Functional characterization of L553N.
Ai) All channels were fully activated at +40mV for 1s before stepping to -120mV for 3s to allow for recovery from inactivation and measure current density. The peak tail current traces for WT (black) and L553N (grey) are shown for the region highlighted in the voltage protocol. Aii) Violin plot of peak tail current amplitudes normalized to cell capacitance. Bi) Typical families of current traces recorded during Isochronal activation protocols, depolarizing the channels from -50mV to +70mV for 1s to activate the channels before stepping to -120mV to record the tail currents, for WT (black) and L553N (grey). Bii) Violin plot of V 0.5 values derived by fitting Boltzmann function to the tail current amplitudes (see Methods for details). Ci) The current traces for WT (black) and L553N (grey) were shown for the region highlighted in the voltage protocol after channels were fully activated at +40mV for 1s before stepping to -50mV for 3s to initiate deactivation. Cii) Violin plot of the weighted time constant (Τ weighted ) for channel deactivation at -50mV, (see methods for detail of calculation of Τ weighted ). In all violin plots, median and quartiles are shown as solid and dotted lines, respectively. The reported two-tailed P-values were derived from Mann-Whitney tests. D) Structural context of L553 (on helix S5), which points between residues V657 and N658 on the S6 helix within the same subunit. Table S1 . Primers used in this study.
Description Sequence
Barcode forward Table S1 are deleterious; the one exception is F551L which PolyPhen-2 predicts is neutral. Grey indicates variant was absent in the library.
